2796. The impact of syndromic molecular point-of-care testing for respiratory viruses on antibiotic use in adults presenting to hospital with exacerbation of airways disease: further analysis from a randomized controlled trial
2796. The impact of syndromic molecular point-of-care testing for respiratory viruses on antibiotic use in adults presenting to hospital with exacerbation of airways disease: further analysis from a randomized controlled trial
Background: the ResPOC study demonstrated that syndromic molecular point-of-care testing (POCT) for respiratory viruses was associated with earlier discontinuation of unnecessary antibiotics. Subgroup analysis suggests this occurs predominantly in patients with exacerbation of airways disease. Molecular POCT use is becoming widespread but there is a lack of evidence to inform the choice between multiplex syndromic panels vs. uniplex tests for influenza.
Methods: we evaluated patients with exacerbation of asthma or COPD who were treated with antibiotics. The duration of antibiotics and proportion with early discontinuation were compared between patients testing positive for viruses by POCT (FilmArray Respiratory Panel) those testing negative by POCT and controls. Patients testing positive for viruses by POCT were compared according to virus types detected. Survival curves were generated for duration of antibiotics and compared using the log-rank test.
Results: there were 118 patient with exacerbation of airways disease in the POCT group who received antibiotics and 111 in the controls. In the POCT group 49/118 (42%) patients tested positive for viruses. Of those testing positive for viruses by POCT 17/49 (35%) had early discontinuation of antibiotics vs. 9/81 (13%) in those testing negative and 7/111 (6%) in controls, P < 0.0001. Survival curve analysis showed a reduced time to antibiotic discontinuation in those testing positive for viruses, P = 0.034. Of those positive for viruses by POCT 20% were positive for influenza, 43% for rhinovirus and 37% for other viruses combined. The proportion with early discontinuation of antibiotics was not different between the virus types, P = 0.53.
Conclusion: syndromic molecular POCT for viruses in adults with exacerbation of airways disease leads to early discontinuation in those positive for viruses. As most viruses detected were non-influenza viruses and there was no difference in antibiotic use between virus types, syndromic molecular POCT for respiratory viruses should be favored over uniplex POCT for influenza.
S988-S988
Clark, Tristan William
712ec18e-613c-45df-a013-c8a22834e14f
Mills, Samuel
bf3525fe-f39a-4896-8ee3-5b60ad704b6f
Brendish, Nathan
a8a4189e-01eb-4ab3-933e-a24cd188a4d7
23 October 2019
Clark, Tristan William
712ec18e-613c-45df-a013-c8a22834e14f
Mills, Samuel
bf3525fe-f39a-4896-8ee3-5b60ad704b6f
Brendish, Nathan
a8a4189e-01eb-4ab3-933e-a24cd188a4d7
Clark, Tristan William, Mills, Samuel and Brendish, Nathan
(2019)
2796. The impact of syndromic molecular point-of-care testing for respiratory viruses on antibiotic use in adults presenting to hospital with exacerbation of airways disease: further analysis from a randomized controlled trial.
Open Forum Infectious Diseases, 6 (Supplement_2), .
(doi:10.1093/ofid/ofz360.2473).
Record type:
Meeting abstract
Abstract
Background: the ResPOC study demonstrated that syndromic molecular point-of-care testing (POCT) for respiratory viruses was associated with earlier discontinuation of unnecessary antibiotics. Subgroup analysis suggests this occurs predominantly in patients with exacerbation of airways disease. Molecular POCT use is becoming widespread but there is a lack of evidence to inform the choice between multiplex syndromic panels vs. uniplex tests for influenza.
Methods: we evaluated patients with exacerbation of asthma or COPD who were treated with antibiotics. The duration of antibiotics and proportion with early discontinuation were compared between patients testing positive for viruses by POCT (FilmArray Respiratory Panel) those testing negative by POCT and controls. Patients testing positive for viruses by POCT were compared according to virus types detected. Survival curves were generated for duration of antibiotics and compared using the log-rank test.
Results: there were 118 patient with exacerbation of airways disease in the POCT group who received antibiotics and 111 in the controls. In the POCT group 49/118 (42%) patients tested positive for viruses. Of those testing positive for viruses by POCT 17/49 (35%) had early discontinuation of antibiotics vs. 9/81 (13%) in those testing negative and 7/111 (6%) in controls, P < 0.0001. Survival curve analysis showed a reduced time to antibiotic discontinuation in those testing positive for viruses, P = 0.034. Of those positive for viruses by POCT 20% were positive for influenza, 43% for rhinovirus and 37% for other viruses combined. The proportion with early discontinuation of antibiotics was not different between the virus types, P = 0.53.
Conclusion: syndromic molecular POCT for viruses in adults with exacerbation of airways disease leads to early discontinuation in those positive for viruses. As most viruses detected were non-influenza viruses and there was no difference in antibiotic use between virus types, syndromic molecular POCT for respiratory viruses should be favored over uniplex POCT for influenza.
Text
ofz360.2473
- Version of Record
More information
Published date: 23 October 2019
Identifiers
Local EPrints ID: 449152
URI: http://eprints.soton.ac.uk/id/eprint/449152
ISSN: 2328-8957
PURE UUID: 7acc3fc2-6d84-4d86-98a3-a5ac194651a3
Catalogue record
Date deposited: 18 May 2021 16:32
Last modified: 21 Nov 2024 02:58
Export record
Altmetrics
Contributors
Author:
Samuel Mills
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics